Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Clinical trial NCT02375880 · COMPLETED

Trial details

NCT number: NCT02375880
Sponsor: Leap Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma of Intrahepatic and Extra-hepatic Biliary System Carcinoma of Gallbladder Bile Duct Cancer Cholangiocarcinoma

Start date: 2015-06-01
Primary completion: 2018-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.